Apnea: Clinical Trials

13 trials for Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 terminated. 13 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Terminated 13
Phase 23Terminated 3

Follow Apnea: new trials by email Literature Review of Apnea trials Research Report on Apnea

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Montelukast for Patients With Obstructive Sleep Apnea Syndrome
Montelukast 10mg, Placebo - Sleep Apnea, Obstructive
Phase 3TerminatedUniversity Hospital, Grenoble12019-11-292021-02-17
Sleep Apnea and Fetal Growth Restriction
S9 VPAP Adapt - Obstructive Sleep Apnea, Fetal Growth Restriction
Phase 3TerminatedWashington University School of Medicine32019-11-182022-03-09
The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea
Oxygen, Room Air - Heart Failure, Central Sleep Apnea
Phase 3TerminatedBrigham and Women's Hospital982019-04-152023-08-01
Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
Caffeine Citrate, Placebo - Apnea of Prematurity
Phase 3TerminatedNICHD Neonatal Research Network8272019-02-272024-07-31
Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
Ketamine, Control - Sleep Apnea, Obstructive Sleep Apnea
Phase 2 / Phase 3TerminatedUniversity of Alabama at Birmingham92016-06-022019-12-19
Morphine in Moderate Obstructive Sleep Apnoea
Morphine sulphate - Obstructive Sleep Apnoea
Phase 3TerminatedPapworth Hospital NHS Foundation Trust62016-05-202018-11-29
OneShot Renal Denervation Registry
OneShot Ablation System - Hypertension, Heart Failure
Phase 2 / Phase 3TerminatedMedtronic Endovascular512014-07-012015-09-02
Right to Left Cardiac Shunt Detection
Flow Detection System - Right to Left Shunt, Patent Foramen Ovale
Phase 3TerminatedCardiox Corporation1412012-11-012015-11-13
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
Desmopressin, Placebo - Nocturia, Obstructive Sleep Apnoea
Phase 3TerminatedChinese University of Hong Kong92012-03-012015-02-04
Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea
Inhalation of low concentration of CO2 - Apnea of Prematurity
Phase 2 / Phase 3TerminatedUniversity of Manitoba72011-10-012015-02-19
Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea
Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical ) - Obstructive Sleep Apnea
Phase 3TerminatedApnex Medical, Inc.1322011-08-012015-04-15
Buspirone as a Potential Treatment for Recurrent Central Apnea
Acetazolamide, Buspirone - Central Apnea, Heart Failure
Phase 3TerminatedVA Office of Research and Development82008-09-012016-03-14
Modafinil to Treat Fatigue in Post-Polio Syndrome
Modafinil - Postpoliomyelitis Syndrome
Phase 3TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)302003-08-012008-08-27

Narrower conditions

Sleep Apnea, Obstructive (7)  ·  Sleep Apnea Syndromes (5)  ·  Heart Failure (3)  ·  Sleep Apnea, Central (3)  ·  Agnosia (1)  ·  Asthenia (1)  ·  Cheyne-Stokes Respiration (1)  ·  Depression (1)  ·  Diabetes Mellitus (1)  ·  Epilepsy (1)  ·  Fetal Growth Retardation (1)  ·  Foramen Ovale, Patent (1)  ·  Heart Septal Defects, Atrial (1)  ·  Hypercapnia (1)

Broader conditions

Respiration Disorders (13)  ·  Respiratory Tract Diseases (13)  ·  Dyssomnias (11)  ·  Nervous System Diseases (11)  ·  Sleep Disorders, Intrinsic (11)  ·  Sleep Wake Disorders (10)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (6)  ·  Sleep Apnea Syndromes (6)  ·  Cardiovascular Diseases (4)  ·  Heart Diseases (4)  ·  Signs and Symptoms, Respiratory (4)  ·  Neurologic Manifestations (3)  ·  Pathologic Processes (3)

Interventions

Acetazolamide (1)  ·  Buspirone (1)  ·  Deamino Arginine Vasopressin (1)  ·  Drug Delivery Systems (1)  ·  Ketamine (1)  ·  Modafinil (1)  ·  Morphine (1)  ·  Oxygen (1)  ·  caffeine citrate (1)  ·  montelukast (1)

Sponsors

Apnex Medical, Inc. (1)  ·  Brigham and Women's Hospital (1)  ·  Cardiox Corporation (1)  ·  Chinese University of Hong Kong (1)  ·  Medtronic Endovascular (1)  ·  NICHD Neonatal Research Network (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Papworth Hospital NHS Foundation Trust (1)  ·  University Hospital, Grenoble (1)  ·  University of Alabama at Birmingham (1)  ·  University of Manitoba (1)  ·  VA Office of Research and Development (1)  ·  Washington University School of Medicine (1)

Countries

United States (8)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Alexander Hincker, MD (1)  ·  Eddie SY Chan (1)  ·  Ian Smith, MBBS (1)  ·  Kingman P. Strohl, MD (1)  ·  Martina Mason, MBBS (1)  ·  Michael W Jopling, MD (1)  ·  Peter A Nagi, MD (1)  ·  Ruben E Alvaro, MD (1)  ·  Waldemar Carlo, MD (1)

Results publications

PMID 34187829, PMID 40294395, PMID 40929650

NIH funding

U10HD036790 (1), U24HL140412 (1), UG1HD021364 (1), UG1HD027851 (1), UG1HD027853 (1), UG1HD027880 (1), UG1HD027904 (1), UG1HD034216 (1), UG1HD040492 (1), UG1HD040689 (1), UG1HD053089 (1), UG1HD053109 (1), UG1HD068244 (1), UG1HD068263 (1), UG1HD068278 (1)